A comprehensive search of the English literature was performed using PubMed (https://www.ncbi.nlm.nih.gov/pubmed) and Google Scholar (https://scholar.google.com/). Clinical research articles on stereotactic laser ablation for brain tumors were selected and evaluated for possible inclusion in the review. Inclusion criteria for study selection were as follows: 1) human study; 2) use of stereotactic laser ablation for brain tumors; and 3) at least a portion of the cohort reported had HGGs (WHO Grade III or IV gliomas). The study results also had to provide a Level IV or better level of evidence. This included randomized, controlled trials; prospective cohort studies; case-controlled studies; retrospective cohort studies; case series; and case reports. Expert opinions, reviews without presentation of clinical data, and reports without HGGs were excluded. Each article was thoroughly reviewed for details on treatments and outcomes.
Neurosurg Focus. 2014;37(6):e1 © 2014 American Association of Neurological Surgeons